CHADOX1 NCOV-19

Intervention

1 paper1 finding

MeSH

  • 1 lab in 1 country
  • Funders: Engineering and Physical Sciences Research Council and 3 more
  • In silico1

Outcomes

1

Antibody response

upin humans1

1 study
  1. CHADOX1 NCOV-19 induces antibody response in humans.

    “individuals over 35 years old twice vaccinated with ChAdOx1-S generate a persistent antibody response suggestive of long-lived plasma cell induction”

    Humanstwo doses

    Mechanistic models of humoral kinetics following COVID-19 vaccination

    Journal of the Royal Society, Interface29 Jan 2025

Latest